tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Morgan Stanley Ceases Substantial Holding in Mayne Pharma

Story Highlights
Morgan Stanley Ceases Substantial Holding in Mayne Pharma

Elevate Your Investing Strategy:

Mayne Pharma Group ( (AU:MYX) ) has provided an update.

Morgan Stanley and its subsidiaries have ceased to be substantial holders in Mayne Pharma Group Limited as of June 12, 2025. This change in substantial holding, which was realized on June 16, 2025, may impact Mayne Pharma’s shareholder structure and could influence market perceptions and investor confidence.

The most recent analyst rating on (AU:MYX) stock is a Buy with a A$7.09 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.

More about Mayne Pharma Group

Average Trading Volume: 962,966

Technical Sentiment Signal: Sell

Current Market Cap: A$412.7M

For detailed information about MYX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1